Salient Features

Zinc phosphate • One of the oldest available luting agents

• Gold standard when compared with newer cements

• Compressive strength: 104 MPa

• Bonds with mechanical interlocking and has low water solubility

• At the time of cementation, pH of the cement is 2.0 and it increases rapidly to 5.5 after

24 h

• Pulpal irritation is likely because of the acidic pH

• Cavity varnish is used to reduce the irritation, but its application reduces retention

Zinc

polycarboxylate

• First cement developed which bonds to tooth chemically

• It has higher tensile strength but lower compressive strength than zinc phosphate

• It shows pseudoplastic behaviour, i.e. increased thinning at increased shear rate

• It also has low pH (4.8), but is less irritant to the pulp because large-sized polyacrylic

acid molecules penetrate less into the dentinal tubules

• It can bond with stainless steel crowns but not with gold

Zinc oxide

eugenol

• This has the least pulpal irritation amongst all available cements

• It has a low compressive strength range between 3 and 55 MPa

• Smaller particle size cement is more stronger

• Usually used as temporary cement

• Presence of eugenol interferes with the polymerization of the composites

• Modified cement can be used as a long-term provisional luting agent.

• o-Ethoxybenzoic acid (EBA) cements are reinforced with alumina oxide

• The compressive strength of improved cement was acceptable but was much low in

comparison to other cements

Glass ionomer

cement

• This is the most commonly used luting agent

• It contains fluoride and has anticariogenic property

• Its compressive strength is 150 MPa and the tensile strength is 6.6 MPa

• Bonds chemically with both enamel and dentine

• Reasonably biocompatible

• Less soluble than zinc phosphate and releases fluorides at a higher rate than silicate

cement

• Vulnerable to postcementation hypersensitivity

• Layer of calcium hydroxide is recommended when cement is applied close to the pulp

• Cement at the crown margin should be protected by applying varnish or petrolatum

• It is more translucent than zinc phosphate cement and chances of metal see through

are possible

Resin cements • These are flowable composites of low viscosity

• These have higher strength than conventional cements

• These have very low solubility

• These cements can be chemically activated or light-activated or dual-cured

• Application of dentine bonding agent is critical for its use, as it reduces the pulpal

sensitivity and microleakage

• The cement bonds by micromechanical means (Fig. 30-1)

• The cement is useful when preparation is confined to enamel and has accessible finish

lines

• These are the luting agents of choice to bond all ceramic inlays, crowns and bridges

• These are available in different shades and give good aesthetic results

Hybrid

ionomer

cements

• These are resin-modified polyalkenoate cements

• These have good strength and low in solubility and also contain fluoride

• These have anticariogenic property

Failures in fixed partial denture (FPD)

Classification of failures in FPD by Bernard G.

Smith

(i) Loss of retention

(ii) Mechanical failure of crown or bridge components: This is

subclassified as follows:

• Porcelain fracture

• Failure of solder joints

• Distortion

• Occlusal wear and perforation

• Lost facings

(iii) Changes in abutment tooth

• Periodontal diseases

• Problems with the pulp

• Caries

• Fracture of the prepared natural crown or root

• Movement of the tooth

(iv) Design failures: This is subclassified as follows:

• Underprescribed bridges

• Overprescribed bridges

(v) Inadequate clinical or laboratory technique: This is subclassified as

follows:

• Positive ledge

• Negative ledge

• Defect

• Poor shape and contour

(vi) Occlusal problems

Factors responsible for FPD failures

The factors can be of three types:

(i) Biological factors

(ii) Mechanical factors

(iii) Aesthetic factors

Biological failure

This includes the following:

• Caries

• Pulp degeneration

• Gingival recession and periodontal breakdown

• Occlusal problems

• Tooth perforation

• Cementation failure

Mechanical failure

This includes the following:

• Loss of retention

• Pontic failure

• Connector failure

• Occlusal wear

• Tooth fracture

• Porcelain fracture

Aesthetic failure

This includes the following:

• Improper shade selection

• Failure to identify patient expectation

• Failure to communicate proper shade to laboratory

• Opaque layer too thick

• Thick metal margin at incisal and cervical regions

• Failure to produce translucency

• Over- or undercontoured crown

• Exposed metal margin in connector, incisal or cervical region.

• Overglazing

Key Facts

• In chronic xerostomic patient, cervical caries and periodontitis are

prime reasons for FPD failure.

• Beilby layer is a microscopic surface layer produced during

polishing of gold crowns.

• Metamerism is a phenomenon of an object appearing of different

colours when viewed under different light source.

• The use of dissimilar metallic restorations in the same mouth may

result in the creation and flow of galvanic currents.

SECTION IV

Maxillofacial Prosthodontics

OUTLINE

31. Introduction and materials

32. Maxillofacial defects and prosthesis

CHAPTER

31

Introduction and materials

CHAPTER OUTLINE

Introduction, 422

Definition, 422

Objectives, 422

Scope, 423

Indications, 423

Contraindications, 423

Effect of Radiation on the Oral Cavity, 423

Oral Mucosa, 423

Bone, 423

Salivary Glands, 424

Taste Buds, 424

Teeth, 424

Periodontium, 424

Evolution of Maxillofacial Prosthesis, 424

Materials Used in Prosthetic Restoration of the Facial Defects, 425

Desirable Properties of Ideal Materials, 426

Definitive Materials Used in Maxillofacial

Prosthesis Fabrication, 426

Stents and Splints Used in Maxillofacial Prosthesis, 431

Splints, 431

Antihaemorrhagic Stent, 432

Introduction

Maxillofacial prosthodontics is a branch of prosthodontics involved in

treating congenital, developed and acquired maxillofacial defects with

variety of techniques and materials. This chapter outlines effects of

radiation on oral tissues and various materials used in maxillofacial

prosthodontics.

Definition

Maxillofacial prosthodontics is defined as ‘the branch of prosthodontics

concerned with the restoration and/or replacement of the stomatognathic and

craniofacial structures with prosthesis that may or may not be removed on a

regular or elective basis’. (GPT 8th Ed)

Maxillofacial prosthesis is defined as ‘any prosthesis used to replace

part or all of any stomatognathic and/or craniofacial structure’. (GPT 8th

Ed)

Objectives

The important objectives of maxillofacial prosthodontics are:

• Restoration of the function

• Restoration of aesthetics

• Therapeutics and healing effect

• Psychological therapy

Scope

• It is an alternative to plastic surgery but not a substitute to plastic

repair.

• Large defects which are not restored with plastic surgery are

rehabilitated by means of appliances or devices used for restoring

the aesthetics and function.

• It is beneficial to patients who refuse further surgery or are at poor

surgical risk for extensive plastic surgery.

Indications

• If anatomical part is not replaced with vital tissues

• When recurrence of malignancy is envisaged

• When radiation therapy is given

• When fragments of the facial bones are displaced in the fracture

• When surgery is not possible due to advanced age, reduced blood

supply, large defect requiring extensive surgery or when the patient

is not willing

• To fabricate a temporary appliance to cover the defect when plastic

surgery repairs require many steps

Contraindications

• When the defect is small and can be restored with surgery.

• When the defect area has good blood supply.

• When prognosis after surgery is good.

Effect of radiation on the oral cavity

Radiation therapy is widely used for the management of malignant

lesions in the oral cavity and other parts of the body. It is used as an

adjunct to surgery or in combination with chemotherapy. The effects

of postradiation are well known and sometimes may result in needless

morbidity. The effects of radiation on the various areas of the oral

cavity are given below.

Oral mucosa

• Initially starts as erythema and leads to extensive ulceration with

severe mucositis.

• Severity of mucositis depends on the area of radiation and the

amount of dose.

• It is most severe in the soft palate followed by mucosa of

hypopharynx, floor of the mouth, buccal mucosa, base of the tongue

and dorsum of the tongue.

• Healing is rapid after radiation therapy and usually completes by 2–

3 weeks.

• Oral candidiasis is the most common complication.

Bone

• As the bone is 1.8 times denser than the soft tissues, it absorbs

considerable amount of radiation than the soft tissues.

• The mandible absorbs more radiation than the maxilla and since it

has reduced blood supply, there is a greater chance of mandibular

osteoradionecrosis.

• The early effe


• The early effect of radiation leads to significant aberration of the fine

vasculature and to progressive occlusion and obliteration of the

smaller blood vessels.

• The late effect of radiation leads to acellularity and avascularity of

the marrow tissues along with its significant fibrosis and fatty

degeneration.

• Gross changes in the bone matrix can make the bone virtually

nonvital.

Salivary glands

• Irradiation of the salivary glands can lead to changes in the

viscosity, pH and organic and inorganic constituents of the saliva.

• Changes in saliva can predispose the patient to caries and

periodontal diseases.

• Deglutition becomes difficult and the patient complains of loss of

appetite.

• With irradiation of the salivary glands, there is progressive

degeneration of the acinar epithelium with increased inter- and

intralobular fibrosis.

• Ultimately, the glands shrink in size and adhere to the surrounding

tissues.

• Retention of the removable prosthesis is compromised due to

reduced flow of saliva.

Taste buds

• Taste buds are readily affected by the radiation therapy and show

signs of degeneration and atrophy.

• There is a partial or complete loss of taste sensation during and

after irradiation.

• Reduction of saliva decreases the number of taste buds and alters

the form and function of the remaining buds.

Teeth

• Irradiation leads to greater chance of teeth decalcification.

• It is believed that pulp undergoes fibrosis and atrophy accompanied

with reduced blood supply.

• The patient may complain of root sensitivity after irradiation.

• High doses of radiation can significantly affect the development of

the tooth leading to various anomalies.

Periodontium

• The network of fibres becomes disoriented and thickening of the

periodontal ligament is evident.

• There is decreased acellularity and vascularity to periodontal

ligament which predisposes it to infection.

• The cementum shows severely reduced capacity to repair and

regenerate.

• Periodontal procedures should be planned with caution, especially

in the mandible.

Evolution of maxillofacial prosthesis

Maxillofacial prosthodontics has evolved many folds over the period

of time. A brief description about the evolution of various prostheses

and materials are given below.

Egyptian mummies: Auricular, nasal and ocular prostheses were

fabricated with various materials.

Before AD 1600, Chinese were known to fabricate nasal and auricular

prosthesis using natural waxes, resins and metals such as

gold/silver.

1541: The first obturator was made by Ambroise Pare which consisted

of a simple disc attached to sponge.

First artificial eye was made of glass in 1579 in Venice.

Tycho Brahe (1546–1601) was famous Danish astronomer who made

an artificial nose of gold and silver.

1710: Pierre Fauchard fabricated a silver mask for a French soldier

named Alphonse Louis who was wounded by shell fragment,

which removed nearly all of the left side of the mandible and

maxilla. The soldier was called gunner with the silver mask.

1800s: William Morton fabricated nasal prosthesis using enamel

porcelain to match the complexion of the patient.

1823: J. Snell fabricated gold plate obturator.

1855: C. Goodyear developed vulcanite rubber used for improved

velar design.

1880: N. Kinsley described a combination of nasal palatal prosthesis

using ceramic material.

1894: F.L.R. Tetamore fabricated a nasal prosthesis of light-weight

nonirritating material called cellulose nitrate developed by John

Wesley Hyatt.

1900–1940: Upham fabricated nasal and auricular prosthesis from

vulcanite rubber.

1905: Ottofy, Baird and Baker reported the use of black vulcanized

rubber for fabricating maxillofacial prosthesis.

1913: Gelatine–glycerine compounds were introduced for use in

facial prosthesis in order to mimic softness and flexibility.

During the same period, V. Kazanjian used celluloid

prints for colouring vulcanized rubber facial

prosthesis.

1937: Acrylic resin was introduced and replaced by vulcanite rubber.

1940–1960: Adolph Brown administered colours in facial prosthesis.

1942: A.H. Bulbian introduced the use of prevulcanized latex for

pliable facial prosthetic restoration.

1953: American Academy of Maxillofacial Prosthetics was formed.

1960–1970: The introduction of various kinds of elastomers resulted in

major changes.

1965: G.W. Barnhart was the first to use silicone rubber for

construction and colouring of facial prosthesis.

1975: A. Koran and R.G. Craig investigated the properties of selected

silicone elastomers, polyvinyl chloride (PVC) and polyurethane.

1976: D.N. Firtell and C.R. Anderson introduced the concept of

combining materials to achieve improved properties.

1977: P.I. Branemark and associates first placed extraoral implant in

the mastoid region to support a bone conduction hearing aid.

1982: A. Udagama and J.B. Drane introduced a new silicone elastomer

(medical adhesive type A, or Dow Corning A-891).

1984: M. Abdelnnabi et al. compared a new material

polydimethylsiloxane (PDMS) with MDX 4-4210.

1987: A. Udagama presented a technique for bonding polyurethane

film to silicone.

1970–1990: J.B. Gonzalez described the use of polyurethane

elastomers.

1988: BAHA, i.e. bone-anchored hearing aid, was approved by the

Swedish health system.

1990s: Rapid prototyping technology used in maxillofacial

prosthodontics is used to create three-dimensional models from a

three-dimensional representation (CT scan or MRI).

2008: 3D printing used to bioprint maxillofacial prosthesis (Fig. 31-1).

2014: 3D Bioplotter is used to create human body parts although it is

still under research.

FIGURE 31-1 Bioprinting of ear prosthesis.

Materials used in prosthetic restoration

of the facial defects

Classification of different materials used in fabrication of maxillofacial

prosthesis is as follows:

On the basis of usage, maxillofacial materials can be broadly

classified as:

(i) Impression materials

• Impression compound

• Irreversible hydrocolloids

• Impression plaster

• Condensation and addition silicones

• Waxes and impression pastes

(ii) Mouldable and sculpting materials

• Modelling clay

• Plaster

• Waxes

• Plastolene

(iii) Definitive materials

• Acrylic resins

• Acrylic copolymers

• Vinyl polymers and copolymers

• Polyurethane elastomers

• Silicone elastomers – heat temperature vulcanizing

(HTV) and room temperature vulcanizing (RTV)

• Metal implants

Desirable properties of ideal materials

• Should have good aesthetic property; it should simulate the colour,

form, texture and translucency of the adjacent natural skin

• Should be easy to fabricate

• Should be biocompatible

• Should have suitable working time

• Should be easily mouldable

• Should be dimensionally stable

• Should be soft, resilient, flexible and simulate the feeling of real

flesh

• Should be easily duplicated

• Should be easily cleaned without damage or deterioration

• Should be easily available and inexpensive

• Should be light in weight

• Should have sufficient edge strength even in thin margins

• Should have low thermal conductivity

• Should be stable during temperature variations

• Should be durable and resistant to stains

• Should be stable when exposed to ultraviolet (UV) rays, oxygen or

adhesive solvents

Definitive materials used in maxillofacial

prosthesis fabrication

Definitive materials used in the fabrication of the maxillofacial

prosthesis are:

• Acrylic resins

• Acrylic copolymers

• Vinyl polymers and copolymers

• Polyurethane elastomers

• Silicone elastomers – HTV and RTV

Acrylic resins

Uses

• These are used in cases where little movement of tissue bed occurs

during function.

• These are used in the fabrication of both intra- and extraoral

prostheses.

• These are derivatives of ethylene and contain a vinyl group in their

structural formula.

Physical properties

• The polymerization can be initiated by UV light or heat as well as by

chemical initiations.

Comments

Search This Blog

Archive

Show more

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

ZENOXIA 15 MG, Comprimé

VOXCIB 200 MG, Gélule

Kana Brax Laberax

فومي كايند

بعض الادويه نجد رموز عليها مثل IR ، MR, XR, CR, SR , DS ماذا تعني هذه الرموز

NIFLURIL 700 MG, Suppositoire adulte

Antifongiques مضادات الفطريات

Popular posts from this blog

علاقة البيبي بالفراولة بالالفا فيتو بروتين

التغيرات الخمس التي تحدث للجسم عند المشي

إحصائيات سنة 2020 | تعداد سكَان دول إفريقيا تنازليا :

ما هو الليمونير للأسنان ؟

ACUPAN 20 MG, Solution injectable

CELEPHI 200 MG, Gélule

الام الظهر

VOXCIB 200 MG, Gélule

ميبستان

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

ZENOXIA 15 MG, Comprimé

VOXCIB 200 MG, Gélule

Kana Brax Laberax

فومي كايند

بعض الادويه نجد رموز عليها مثل IR ، MR, XR, CR, SR , DS ماذا تعني هذه الرموز

NIFLURIL 700 MG, Suppositoire adulte

Antifongiques مضادات الفطريات

Popular posts from this blog

Kana Brax Laberax

TRIPASS XR تري باس

PARANTAL 100 MG, Suppositoire بارانتال 100 مجم تحاميل

الكبد الدهني Fatty Liver

الم اسفل الظهر (الحاد) الذي يظهر بشكل مفاجئ bal-agrisi

SEDALGIC 37.5 MG / 325 MG, Comprimé pelliculé [P] سيدالجيك 37.5 مجم / 325 مجم ، قرص مغلف [P]

نمـو الدمـاغ والتطـور العقـلي لـدى الطفـل

CELEPHI 200 MG, Gélule

أخطر أنواع المخدرات فى العالم و الشرق الاوسط

Archive

Show more